United States · Bill · S
S. 1049 (115th)
Opioid Addiction Risk Transparency Act
Introduced
4 May 2017
Last action
4 May 2017 · Introduced
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsors
Sen. Hassan, Margaret Wood [D-NH], Sen. Young, Todd [R-IN]
Subjects
Healthcare
Source updated
11 August 2025
Summary
Opioid Addiction Risk Transparency Act This bill amends the Federal Food, Drug, and Cosmetic Act to authorize the Food and Drug Administration to require a communication plan that is part of a medication's risk evaluation and mitigation strategy to include informing health care providers about the meaning of terms related to properties of the medication described in the labeling.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
4 May 2017
Introduced
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Source: IntroReferral
4 May 2017
Introduced
Introduced in Senate
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in Senate · 4 May 2017 · Download file
Documents
3 official files
Introduced in Senate (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in Senate (text)
Introduced in Senate · EN · 4 May 2017
Introduced in Senate (PDF)
Introduced in Senate · EN · 4 May 2017
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in Senate
summary · EN · 4 May 2017
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Sen. Hassan, Margaret Wood [D-NH] · D · Sponsor
- Sen. Young, Todd [R-IN] · R · Sponsor
- · sshr00 · Standing
Related records
- related to → FDA Reauthorization Act of 2017
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/115th-congress/senate-bill/1049
- Open data entity: https://api.congress.gov/v3/bill/115/s/1049
- us · 115-s-1049 · source updated 11 August 2025